Newmark Security - Discovered Gem

TK >> if you remember the targets were set 2 years ago just after the purchase of Custom Micro, and Hatto, kindly visited them for us and gave his feedback before i posted.

After the results, that year, i revisited my targets and re-adjusted them based on the worsening long term creditors figures to 7p - 11p. The timeframes remaind static (c2007), so we still have a fair way to go.

I bought back in recently at 1.35p, on the strenght that i felt they were too cheap at that price.

From my recent research i beleive the figures in Jan will be encouraging and better later in the the year, as the loss makers have now gone. (there'll be some exceptionals in the Jan numbers).

I still remain confident the NWT will move towards the bottom end of my target towards the end of 2006 and maybe more if and a big IF, the company, as stated 18 months ago, look to pay a token divi.

TK as you'll be aware i sometimes do get it very wrong, just look at MRD, what a dog that turned out to be. Everyone sitting now on at least 50% losses with no hope of getting anything back.

however the other 12 tips over the last 5 / 6 years have all performed.

I posted my 5 for 2006 on the AHT thread last week.

here they are, but as always pls DYOR.

OVG (now 10p) target 50p, they've bought a silver mine in Russia, they expect to generate over £10m per year profit, the mkt cap is only £10m

PET (now 55p) target 160p, it may be a gamble, but they must pick up something in Iraq, they've also drilling to commence in Jordan, once the conract has been ratified by the King and the Jordanian government.

ELA (now c11 euros) target 22.50 euros, Tysabri will be back in the market before the end of March, (drug treats MS)

CEN (now 8p) target 24p, they will be filing for European product approval of M6G in summer 2006, CNS 5161, will be moved to the next phase of development, (which could be CEN's blockbuster), COMT Parkinsons inhibitor, will be moved on to the next phase of it's trials and CEN will file for an "IND" with the FDA for the drug CNS 7056X.

GLD (now 23p) target 35p, feel they will be aquired by Constellation group early next year.

as always PLS DYOR

best of luck Avoint Knowing